Introduction Imagine result Case Report Comment

Slides:

Advertisements

Similar presentations

台北榮總血液腫瘤科楊元豪 / 高志平大夫. 2 Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only potentially curative treatment in patients.

Advertisements

A single centre study of the efficacy of extracorporeal photopheresis in Acute Graft Versus Host Disease Lynne Watson Nottingham University Hospital NHS.

Blood and marrow stem cell transplantation A.Basi ADULT HEMATOLOGIST,ONCOLOGIST IRAN UNIVERSITY OF MEDICAL SCIENCES.

Cryptococcal pneumonia and meningitis. Cryptococcus neoformans.

CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS Stephen J. Gluckman, M.D. Botswana-UPENN Partnership.

Pulmonary complications in a child with AML CHILDREN’S HOSPITAL & RESEARCH CENTER OAKLAND Hazel Villa, MD.

DR. YETUNDE T. ISRAEL-AINA PAEDIATRICIAN, UNIVERSITY OF BENIN TEACHING HOSPITAL, BENIN CITY BENIN BLOOD AND MARROW TRANSPLANT WORKSHOP, UNIVERSITY OF BENIN.

Antifungal therapy: Polyenes, posaconazole, or prayers Michael Kleinberg, MD, PhD Associate Professor of Medicine Head, Infectious Diseases Section Marlene.

NYU Medical Grand Rounds Clinical Vignette Lindsay Innes, MD PGY2 September 20, 2011 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

CMV (Cytomegalovirus) reactivation and immunosupression in allogeneic transplantation Marie Waller Bone Marrow Transplant Coordinator Manchester Royal.

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Aspergillosis Slide Set Prepared by the AETC.

Reduced-Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (allo-SCT) for Relapsed/Refractory Hodgkin Lymphoma (HL) in the Brentuximab.

Successful sequential cord blood stem cell transplant and intestinal-colon transplant for combined immunodeficiency and intestinal failure.

Altered mental status post transplant 66 year-old woman h/o diabetes mellitus s/p deceased donor renal transplantation One year post transplant admit to.

Single-Agent Lenalidomide Induces Complete Remission of Acute Myeloid Leukemia in Patients with Isolated Trisomy 13 Fehniger TA et al. Blood 2009;113(5):

TREATMENT. Phases of treatment Induction chemotherapy Postremission therapy *Initial goal: quickly induce CR *Therapy depends on patient age.

Treatment. Phases of treatment Induction chemotherapy Postremission therapy *Initial goal: quickly induce CR *Therapy depends on patient age.

Case report Sudden blastic transformation in patient with chronic myeloid leukemia treated with imatinib mesylate Mehrdad Payandeh,MD Hematology, Medical.

Daunorubicin VS Mitoxantrone VS Idarubicin As Induction and Consolidation Chemotherapy for Adults with Acute Myeloid Leukemia : The EORTC and GIMEMA Groups.

Abstract Immune Reconstitution and Clinical Outcome After Donor Lymphocyte Infusion for Relapsed Disease After Reduced-Intensity Allogeneic Hematopoietic.

Hematopoietic Stem Cell Transplantation (HSCT)

Timothy W. Felton, Caroline Baxter, Caroline B. Moore, Stephen A.Roberts, William W. Hope,and David W. Denning Clinical Infectious Diseases 2010; 51:1383–1391.

Margaret L. Green, Wendy M. Leisenring, Hu Xie, Roland B. Walter, Marco Mielcarek, Brenda M. Sandmaier, Stanley R. Riddell and Michael Boeckh Blood NUM.

Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation.

Pavan Kumar Bhamidipati 1, John F. DiPersio 1, Keith Stockerl-Goldstein 1, Geoffrey L. Uy 1, Peter Westervelt 1, Feng Gao 2, Ravi Vij 1, Mark A. Schroeder.

Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.

Haploidentical BMT with a Post-Infusion of Stem Cells Cyclophosphamide Approach is Feasible and Leads to a High Rate of Donor Engraftment in Haemoglobinopathies.

VALDEZ ET AL CLINICAL INFECTIOUS DISEASES 2011;52(6):726–735 R2 Kim Dong Hyun Decreased Infection-Related Mortality & Improved Survival in Severe Aplastic.

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Histoplasmosis Slide Set Prepared by the AETC.

Time to neutrophil engraftment Time to platelet engraftment

RIC UCBT Transplantation of Umbilical Cord Blood from Unrelated Donors in Patients with Haematological Diseases using a Reduced Intensity Conditioning.

Bachar Samra MD1, Jacques Azzi MD1, Ambreen Khalil MD2.

Haematopoietic stem cell transplantation alongside enzyme replacement therapy in infantile onset lysosomal acid lipase deficiency Ghosh A1, Lum SH2, Jones.

Retrospective analysis of conditioning regimen containing decitabine of allogeneic stem cell transplantation for myelodysplastic syndrome and myeloproliterative.

Respiratory diseases caused by fungi

Posterior Reversible Encephalopathy Syndrome associated with Cyclosporine use in a child undergoing allogeneic Hematopoietic Stem Cells Transplantation.

This is an archived document.

Pulmonary Zygomycosis

Case Western Reserve University and University Hospitals of Cleveland

EXPERIENCE WITH ALEMTUZUMAB IN KIDNEY TRASPLANTATION

CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS

Haploidentical Transplantation with Post-transplant Cyclophosphamide and Melphalan-based Conditioning– A retrospective Analysis of the First 100 Patients.

Per microtrasplantation

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors.

Pulmonary complications in a child with AML

Allogeneic stem cell transplantation (allo-SCT) is a potentially curative procedure for a variety of malignant and nonmalignant conditions. Historically,

Gupta V, Tallman MS, Weisdorf DJ

Y. Hicheri, G. Cook, C. Cordonnier Clinical Microbiology and Infection

Il trapianto allogenico da donatore alternativo dopo condizionamento a ridotta intensità Alessandro Rambaldi.

PREDICTIVE FACTORS AFFECTING THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION USING RIC REGIMENS: EXPERIENCE FROM A SINGLE CENTRE Dott.ssa M. Medeot.

Parasitology department

Patient charactaristics:

Ematologia, Ospedali Riuniti, Bergamo

Y. Hicheri, G. Cook, C. Cordonnier Clinical Microbiology and Infection

CombinationTreatment

OUTPATIENT-BASED AUTOLOGOUS STEM CELL TRANSPLANTATION: FEASIBLE, SAFE AND COST EFFECTIVE APPROACH Hani Al Hashmi, Panayotis Kaloyannidis, Eshrak Al Shibani,

Introduction Case Report Conclusion

Conclusions/Comments

Reduced-Intensity Allogeneic Stem Cell Transplantation in Adults and Children with Malignant and Nonmalignant Diseases: End of the Beginning and Future.

Letermovir(Prevymis™) Guidelines for Inpatient Use

The Pentostatin Plus Cyclophosphamide Nonmyeloablative Regimen Induces Durable Host T Cell Functional Deficits and Prevents Murine Marrow Allograft Rejection

CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia

N.M.A. Blijlevens, J.P. Donnelly, B.E. de Pauw

A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning.

Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring.

The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion

A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for High-Risk Acute Leukemia: Successful Engraftment and Mild GVHD

Bridge to transplant following Bv+Bs regimen.

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma by Damian J. Green, David G.

Frédéric Baron, Rainer Storb

Presentation transcript:

Introduction Imagine result Case Report Comment Dematiaceus fungi related pulmonary infection post hematopoietic stem cell transplantation from a haploidentical donor: a case report Al Shaibani Eshrak, Al Yousef W, Mokhtar Nihad, Kawari Mohammed, Bakhit Khalid, Abulhassan Ayman, Alharbi Salman, Suhebeh Ashraf, Soudi Hamdi, Apostolidis John, Hani Al Hasmi, Khalid Al Anezi, Kaloyannidis Panayotis Adults Hematology and Stem Cell Transplantation Department King Fahad Specialist Hospital Dammam Saudi Arabia Introduction Imagine result Dematiaceous fungi (DF) infections are increasingly seen in allografted and immunocompromised patients, affecting usually skin, lungs, brain while also disseminated disease has been reported. No standardized therapy exists, triazoles and Liposomal-Amphotericin-B (L-AmB) have been successfully used as treatment. Sputum culture: - Satin by lactophenol examination, confirm the diagnosis. Treatment: - Posaconazole (200mg tid) plus IV L-AmB (5mg/kg). Response: - Symptoms completely resolved after 7 days. - Repeated sputum cultures revealed no detectable DF. - Posaconazole continue as maintenance . - 3 months later, she remains in complete remission without evidence of fungal infection. Case Report An 35 years old female, who underwent allogeneic stem cell transplantation from a haploidentical donor for localized (mediastinum) myeloid sarcοma. Clinical course: Pre-transplant: - Cytarabine and Idarubicin (3+7 regimen). - High-dose Cytarabine (3 cycles). - Involved field irradiation. Transplant course: - Conditioning regimen consisted of Thiotepa / Busulfan/ Fludarabine. - CD34+ cell 4.5x106/kg unmanipulated from peripheral blood. - GvHD prophlaxsis: Post-transplant Cyclophosphamide (days: +3, +5). Cyclosporine (CSP). Mycophenolate Mofetil (MMF) - Antibiotic prophylaxis: Fluoroquinolone, acyclovir and voriconazole. Post transplant: - Engraftment ANCs>500/mm3 (day +18) PLTs>25000/mm3 (day +11) while from - Day+14 chimeric study 100%. - Complication: * Day+14: acute-GvHD(grII) that successfully controlled with steroids additionally to CSP and MMF. * Day+30: productive cough, without fever was not responding to antibiotics. Comment Heavily immunosuppressed patient, the combination of Posaconazole plus L-AmB proved to be highly effective. Combined antifungal treatment for these aggressive DF infections needs further investigation